Related by context. All words. (Click for frequent words.) 85 M2 subunit 74 accumulate preferentially 73 colorectal bladder 73 gastrointestinal stromal 73 gastro intestinal inflammation 72 specific lectin receptors 72 chemically modified siRNA 72 metastatic colorectal 72 NS5b 72 PLX MS 71 triggers apoptosis programmed 71 modulate ion channel 71 prostate cancer antigen prostatic 71 metastatic pancreatic 71 CEA CD# Her2 70 castration resistant hormone refractory 70 colorectal ovarian 70 signal transduction inhibitors 70 deCODE ProstateCancer TM 70 CYT# potent vascular disrupting 70 bladder ovarian 70 RAS MAPK pathway 70 including HGF ErbB3 70 IgG1 monoclonal antibody 70 humanized therapeutic 69 sirtuin inhibitor program 69 humanised monoclonal antibody 69 CDK cyclin dependent 69 adhesion molecule EpCAM expressing 69 alpha folate receptor 69 ATRA IV 69 platform HDL Mimetic 69 IAP inhibitor 69 RON Notch 69 infectious diseases autoimmune diseases 69 kidney urologic 69 commercializing oxidized glutathione 69 pancreatic bladder 69 hormone refractory prostate 69 rotavirus shingles 69 Factor Receptor 69 secretory phospholipase A2 68 ovarian breast 68 angina nausea 68 advanced metastatic renal 68 IMiDs ® 68 sarcoma melanoma 68 Protein Kinase C 68 cause mesothelioma asbestosis 68 insomnia migraine headaches 68 pancreatic colon 68 AAG geldanamycin analog 68 demonstrated anti amnesic 68 GRNOPC1 contains 68 POTELLIGENT ® Technology 68 Ph + acute lymphoblastic 68 ASONEP TM 68 multiple sclerosis psoriasis 68 Smac mimetics 68 metastatic renal 68 Panzem NCD 67 DG# compounds targeting 67 ovarian endometrial 67 acid phosphatase PAP 67 novel tubulin binding 67 sulfonylhydrazine class 67 cardio metabolic diseases 67 Alfacell proprietary ribonuclease 67 EGFr expressing metastatic colorectal 67 lung pancreatic 67 delay bone metastases 67 pralatrexate injection folate analogue 67 antiangiogenesis therapies 67 inflammation autoimmune diseases 67 endometrial breast 67 dasatinib Sprycel ® 67 progressive metastatic prostate 67 ATC ovarian cancer 67 humanised antibody designed 67 basal cell carcinoma squamous 67 Pruvel TM 67 novel therapeutic antibodies 67 Provectus Pharmaceuticals specializes 67 oncolytic virus therapies 67 Imatinib mesylate 67 specific membrane antigen 67 Prednisone Against Refractory 67 targeted immunotherapies 67 selectively induce apoptosis 67 MKC# MT 67 attach auristatin 67 ovarian colon 67 identify protein biomarkers 67 BCG refractory carcinoma 67 pancreatic prostate 67 A3 adenosine receptor 67 recurrent metastatic ovarian cancer 67 Therapies SRT 67 protein receptors lectins 67 selectively inhibit replication 67 investigational immunotherapy 66 Glioblastoma multiforme GBM 66 proprietary polysaccharide 66 VitiGam 66 novel immunotherapies 66 treat atopic dermatitis 66 ovarian prostate 66 c Raf kinase 66 MCSP respectively 66 psoriasis rheumatoid arthritis 66 multi kinase inhibitor 66 selective angiogenic kinase inhibitor 66 monoclonal antibody MAb 66 candidates Azedra TM 66 ChromoCure develops 66 selectively inhibited 66 Cobalamin TM mediated 66 refractory metastatic 66 neurodegenerative diseases Alzheimer disease 66 Dendreon investigational 66 leukemia multiple myeloma 66 5 HT2A serotonin 66 ASONEP ™ 66 antibody MT# 66 anti PlGF 66 modified glutathione analog 66 urinary bladder wall 66 anionic backbone 66 Tumour VDA 66 essential thrombocythemia ET 66 #T# tumor 66 oral kinase inhibitor 66 pancreas esophagus 66 LymphoStat B belimumab 66 immunotherapeutic approaches 66 GVAX ® 66 indolent follicular non 66 ovarian pancreatic 66 interferon alpha IFN 66 imatinib Gleevec ® 66 humanized monoclonal antibodies 66 psoriasis inflammatory bowel 66 selective kinase inhibitor 66 erlotinib Tarceva ® 66 systemic anaplastic large 66 cardiovascular restenosis cancer 66 AVAX AC Vaccine 66 CD# expressing 66 Platinum Resistant Ovarian 66 targeted radiotherapeutic 66 Palifosfamide delivers 66 diseases osteoarthritis osteoporosis 66 protein tyrosine phosphatase 1B 66 commercialize deforolimus 66 HCV NS5B polymerase 65 BEMA TM Buprenorphine 65 LHRH receptor positive 65 liver colon rectal 65 CCR9 antagonist 65 targeted antifolate 65 resistant hormone refractory 65 PDE# 65 pathophysiological effects 65 NPC 1C 65 drug conjugate 65 novel orally administered 65 metastatic androgen independent 65 sunitinib Sutent ® 65 IMiDs R 65 candidate Lovaxin C 65 targeting miR 65 antibody trastuzumab 65 anticancer therapeutics 65 apoptosis proteins 65 hypercholesterolemia liver 65 plus dacarbazine 65 radiation chemoradiation 65 dysplastic lesions caused 65 neovascular diseases 65 myelofibrosis polycythemia vera 65 hepatitis C lupus 65 Additional BiTE antibodies 65 agonistic human 65 anti gastrin monoclonal 65 Tumour Vascular Disrupting Agent 65 Trastuzumab DM1 65 CD# antibody [002] 65 lupus hepatitis C 65 vinca alkaloid 65 FUSILEV enhances 65 XOMA 3AB biodefense 65 pips #,# +# pips 65 antigen CD# 65 chimeric monoclonal antibody 65 unresectable tumors 65 novel antimitotic agent 65 tumors GIST 65 PNP inhibitor 65 induce apoptosis programmed 65 pancreatic lung 65 specific chemokine receptors 65 Sphingomab 65 Ep CAM 65 leukemia lymphoma multiple myeloma 65 taxane derivative 65 dependent cellular cytotoxicity 65 targeting CD# 65 HGS ETR1 mapatumumab 65 MTP inhibitor 65 R Saizen R 65 abnormal p# 65 tongue mouth pharynx 65 antisense therapies 65 GVAX Immunotherapy 65 chemosensitizer 65 TLR7 agonist 65 OMP #R# 65 poly ADP ribose polymerase 65 epithelial tumors 65 ADCC enhanced 65 Vidaza ® 65 metastatic bladder 65 non porcine pancreatic 65 deCODE AF TM 65 NeoLipid R 64 mTOR mammalian target 64 Ribavirin causes 64 4 PDE4 enzyme 64 antimitotic 64 Transdrug R 64 Current Lm vaccines 64 class mGluR5 inhibitor 64 protein kinase inhibitor 64 pelvic malignancies 64 applying Lipid Sciences 64 OncoVex 64 Systemic lupus erythematosus SLE 64 novel VDA molecule 64 polysaccharide polymer 64 Monoclonal antibody 64 comprise Alnylam RNAi 64 RhuDex R 64 treat musculoskeletal metabolic 64 Aflibercept 64 osteolytic bone disease 64 NASH Huntington 64 treating sarcoma testicular 64 Multiple Sclerosis Rheumatoid Arthritis 64 biomarkers predictive 64 stem cells CSCs 64 OMP #M# 64 alkylating 64 breast ovary 64 investigational antibody 64 leukemia myeloma 64 nilotinib Tasigna ® 64 peptidic compound 64 Enzastaurin 64 Vicinium TM 64 mGluR4 mGluR2 mGluR5 64 human IgG1 monoclonal 64 advanced malignant hepatic 64 inhaled TPI ASM8 64 dasatinib Sprycel 64 brand ciclesonide HFA 64 MAGE A3 ASCI 64 HyperAcute 64 therapeutic monoclonal antibody 64 whose tumors overexpress 64 castrate resistant prostate cancer 64 metastatic carcinoid 64 somatostatin receptors 64 Quinamed R 64 INSPIRE Trial Phase III 64 hormonally sensitive 64 engineered proteases 64 hormone gastrin 64 ImmunoGen TAP technology 64 receiving chemoradiation therapy 64 evaluating picoplatin 64 HER2 HER2 64 thromboxane A2 64 antibody MAb 64 Sphingomab TM 64 monoclonal antibody IgG1 Mab 64 MT#/MEDI-# 64 deCODE BreastCancer 64 molecule epidermal 64 commercializes oncology 64 Emergent marketed 64 gastrointestinal stromal tumors GISTs 64 CFTR corrector 64 Epidermal Growth Factor Receptor 64 humanised antibody 64 recombinant subunit vaccine 64 Inc. AMEX YMI 64 Namenda Memantine HCl 64 atherosclerosis rheumatoid arthritis 64 neovasculature 64 investigational monoclonal antibody 64 targeted anticancer biopharmaceuticals 64 relapsed leukemia 64 tumor activated prodrug 64 lymphoma multiple myeloma 64 Shark cartilage 64 Company Nasdaq RGDX 64 immunologic diseases 64 receptor inhibiting monoclonal 64 irinotecan doxorubicin oxaliplatin paclitaxel 64 receptor tyrosine kinase inhibitor 64 oral Janus kinase 64 evaluating T DM1 64 CYP#A# CYP#D# 64 AKT inhibitor 64 hematological diseases 64 Romidepsin 64 included exfoliative dermatitis 64 Crucell genetically engineered 64 Elotuzumab 64 Study Tanning beds 64 high mannose structures 64 colon pancreatic 64 HER1 64 IMiDs ® compound 64 AN# topical anti 64 developing Surfactant Replacement 64 colorectal lung 64 glycoproteins residing 64 certain protein tyrosine 64 immunotoxin 64 Strep Staph 64 colorectal gastric 64 rhabdoid 63 oral TLR7 agonist prodrug 63 ErbB2 positive 63 Phase 1b clinical trials 63 virus HCV protease inhibitor 63 BRAF mutant 63 collagen vascular 63 epithelial origin 63 HuCAL PLATINUM ® CysDisplay 63 Darapladib 63 include Healive TM 63 recurrent metastatic 63 systemic RNA interference 63 Hsp# Inhibitor 63 adjuvant GIST 63 demonstrated antitumor activity 63 mda 7 63 Nasdaq IMGN biotechnology 63 huC# DM4 63 related CMV Retinitis 63 targets Galectin receptors 63 used DNA alkylating 63 Basal Cell 63 Basal cell 63 hypereosinophilic syndrome 63 systemic RNAi therapeutic 63 TNF Tumor Necrosis Factor 63 breast pancreatic 63 Amgen Neulasta R 63 Relapsed Refractory 63 lesser extent polymetallic 63 filter cytokines 63 Sudhir Agrawal D.Phil 63 vaccines oncolytic virus 63 TRIOLEX HE# APOPTONE HE# 63 MAbs targeting 63 Bayer HealthCare Onyx Pharmaceuticals 63 5 HT4 63 potent antiproliferative 63 endometrial ovarian 63 activin receptor type 63 Epigenomics proprietary 63 tests miRview TM 63 Archexin 63 abnormal hematopoietic cells 63 thetreatment 63 mertansine 63 lintuzumab SGN 63 reversible inhibitor 63 diseases fat malabsorption 63 treat chronic rhinosinusitis 63 carcinoma HCC 63 invasive lobular 63 delta gamma agonist 63 5 FU leucovorin 63 ovarian bladder 63 cisplatin resistant 63 oral prodrug 63 VEGFR2 inhibitor 63 refractory gastrointestinal stromal 63 IMPDH inhibitor 63 ALTROPANE R 63 toxicogenomic assessment 63 AVEO Pharmaceuticals NASDAQ 63 lymphoma myeloma 63 developing KL4 surfactant 63 AVEO proprietary 63 5 fluorouracil leucovorin 63 neuroendocrine cancers 63 allogeneic epidermal 63 Crofelemer budesonide foam 63 vinca alkaloids 63 gefitinib Iressa 63 androgen receptor antagonist 63 esthesioneuroblastoma rare form 63 Solazed TM 63 Notch receptors 63 multiple sclerosis rheumatoid arthritis 63 colon carcinomas 63 Akt pathway associated 63 D aspartate NMDA receptor 63 Indibulin ZIO 63 IGF IR 63 Daclizumab 63 damage cirrhosis liver 63 SinuNase ™ 63 Rigel R# 63 Azixa MPC 63 drug conjugates ADCs 63 MEK ERK 63 CysDisplay R 63 indications Cytokinetics 63 dihydrofolate reductase DHFR 63 sapacitabine CYC# 63 Annamycin 63 B Anflu R 63 NS#/#A protease 63 proprietary delipidation technologies 63 mTOR kinase 63 regulate therapeutically important 63 HSP# inhibitor 63 novel immunotherapeutic 63 fluoroquinolone class 63 XL# anticancer compounds 63 Photodynamic therapy PDT 63 CD4 monoclonal antibody 63 taxane chemotherapy administered 63 Immunotherapeutic 63 oral picoplatin 63 inhibits Akt activation 63 c MET 63 Squamous cell 63 TNF alpha selectively neutralizing 63 sorafenib tablets 63 vinorelbine tartrate 63 RAF kinase 63 include ColorectAlert TM 62 novel peptide 62 refractory chronic lymphocytic 62 CIMZIA r certolizumab pegol 62 osteoporosis osteoarthritis 62 naloxol derivative 62 androgen receptor AR 62 Deforolimus 62 tumor angiogenesis inhibitors 62 Cotara ® 62 INS# [001] 62 renal failure interstitial lung 62 MMAE 62 dermatology therapies 62 interferon beta 1a infertility 62 PF # [002] 62 Antibody Drug Conjugate 62 forodesine purine nucleoside phosphorylase 62 chronic inflammations 62 BRAF inhibitor 62 chemoattractant receptors 62 FBPase 62 inflammation metabolic disorders 62 Maintain Overweight rating 62 PEGylated Fab fragment 62 oncologic diseases 62 CYT# vascular disrupting 62 MSCRAMM ® 62 lung ovary 62 treating neuropathic pain 62 platforms GVAX 62 histone deacetylase HDAC inhibitors 62 ErbB3 HER3 62 Delta opioid receptor 62 rheumatoid arthritis thrombocytopenia 62 Phase #b/#a clinical 62 Locked Nucleic Acid 62 Shows Promise Against 62 M# rationally 62 deposited preferentially 62 paclitaxel cisplatin 62 hormone refractory metastatic prostate 62 TRPV1 agonist 62 Pharma Merck Serono 62 Temsirolimus 62 untreated metastatic pancreatic 62 hormone LHRH antagonist 62 histone deacetylase HDAC 62 purified inactivated vaccine 62 semi synthetic lipoglycopeptide 62 diagnostic molecular imaging 62 BRAF kinase 62 Alzheimer disease cognitive impairment 62 Squamous 62 TTR gene 62 orally administered inhibitor 62 drug conjugate ADC 62 calcitonin gene related 62 #,# +# 62 hypoxia activated prodrug 62 Cytotoxic T 62 vaginal candidiasis 62 recurrent glioblastoma multiforme 62 R sorafenib tablets 62 CD# molecule 62 TRAIL R2 62 B lymphocyte stimulator 62 triciribine phosphate monohydrate 62 myelodysplastic myeloproliferative diseases 62 PDE4 modulators 62 GMX# 62 developing Surfactant Therapies 62 pertuzumab 62 humanized monoclonal antibody 62 RNA antagonists 62 IgG1 antibody 62 STOP SHOPPING FOR 62 Ovitrelle R Serostim 62 cellular immunotherapy 62 drug monomethyl auristatin 62 BiTE ® 62 PLX STROKE targeting 62 Pruvel ™ 62 oral ghrelin agonist 62 particularly SANCTURA XR 62 Epidermal Growth Factor 62 Septin9 biomarker 62 autoimmune disorders asthma 62 mutated BRAF gene 62 Aplidin 62 ovarian esophageal 62 Her2 positive 62 tests miRview ™ 62 potently silencing specific 62 Combination REOLYSIN R 62 Like Waitz Aanesen 62 pediatric acute lymphoblastic 62 E7 proteins 62 brivanib 62 psoriasis atopic dermatitis 62 Bavituximab 62 RhuDex TM 62 Amgen discovers develops 62 burgeoning grievous 62 investigational humanized monoclonal antibody 62 engineered RAP peptides 62 herpes simplex viruses 62 delivers fluocinolone acetonide FA 62 melanoma ovarian 62 Darinaparsin 62 TRISCUIT crackers 62 Angiolix R 62 Locked Nucleic Acid LNA 62 investigational therapies 62 glutamic acid decarboxylase 62 Aflibercept VEGF Trap 62 fusion enhancers 62 doxorubicin Transdrug R 62 ARRY # 62 TLR9 agonists 62 Acute myelogenous leukemia 62 GRN# 62 multitargeted 62 testing huN# DM1 62 Personalized Immunotherapy 62 Company TAIFUN R 62 Tykerb lapatinib 62 cyclin dependent kinase inhibitor 62 bone marrow lymph nodes 62 siRNA therapeutic 62 PCA3 gene 62 Menopausal hormone therapy 62 proteasome inhibitor 62 telomerase reverse transcriptase 62 Telik logo TELINTRA 62 refractory indolent non 62 metaglidasen 62 Pertuzumab 62 IMC #B 62 plus fludarabine 62 novel immunomodulatory 62 mitogen activated ERK kinase 62 investigational oral inhibitor 62 psoriasis Crohn disease 62 alpha 2A adrenergic 62 Inc. OTCBB BMSN 62 Ceflatonin 62 Small Modular SMIP 62 liposomal formulation 62 Ii protein 62 ZACTIMA TM ZD# 62 intravesical infusion therapy 62 neuropathic pain spasticity 62 recombinant PSMA vaccine 62 novel emulsion formulation 62 lead molecular radiotherapeutic 62 tubulin binding 62 HUMIRA resembles 62 active AKT inhibitor 62 commercialize SGN 62 highly selective inhibitor 62 therapeutic monoclonal antibodies 62 potent inducer 62 clinical trials Archexin 62 SIX RO ROG 62 Sapacitabine 62 rxRNA 62 histone deacetylase HDAC inhibitor 62 VitiGam TM 62 trastuzumab Herceptin R 62 candidate deforolimus 62 FGFR 62 albumin naturally occurring 62 metastatic ocular 62 myeloproliferative neoplasms MPNs 61 Achieves Primary Endpoint 61 pneumocystis pneumonia PCP 61 Zalypsis 61 preferentially bind 61 oral dihydropyrimidine dehydrogenase DPD 61 ZFP Therapeutics 61 ImmunoGen DM1 cancer 61 thalidomide Thalomid 61 BRAF mutated 61 Vaccine Adjuvant 61 pan histone deacetylase 61 anti atherothrombotic 61 AGS PSCA 61 agent VDA 61 StromaCel Inc. 61 apoptosis induced 61 Panzem R 61 EGFR pathway 61 transthyretin TTR 61 SPL# Gel vaginal microbicide 61 Prodarsan R 61 stage IIIb IV 61 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 61 Micromet proprietary BiTE 61 DCVax R 61 uterine ovarian 61 iobenguane 61 TRAIL induced apoptosis 61 Talabostat 61 Carcinoid tumors 61 Hsp# inhibition 61 anti botulism antibody 61 onychomycosis psoriasis acne 61 anxiety palpitations dizziness 61 HIV AIDS neuropathic pain 61 TTR amyloidosis 61 collagen sponge seeded 61 Initiates Clinical Trial 61 commercializing dermatological products 61 selective inverse agonist 61 Nasdaq HALO biopharmaceutical 61 PDGFR B 61 Kinase Inhibitor 61 Blinatumomab 61 BRCA deficient 61 rheumatoid arthritis inflammatory bowel 61 Squamous Cell 61 Epratuzumab 61 ANGPTL4 61 irreversible inhibitor 61 Crizotinib 61 optimized siRNA 61 drug Treanda 61 FOLFOX6 chemotherapy regimen 61 Initiates Enrollment 61 Vitaxin 61 orally inhaled migraine 61 bispecific antibodies 61 inflammatory PDE 61 microtubule inhibitor 61 TNFerade TM 61 tubulin inhibitor 61 Slows Progression 61 telomerase inhibitor 61 immunocompetent adults 61 Treatment Shows Promise 61 hip osteonecrosis avascular 61 Budesonide foam crofelemer 61 SuperAntibody 61 PI3K/Akt pathway inhibitor 61 tested eribulin 61 Nanobody 61 hypoxia selective 61 evaluating satraplatin 61 rheumatoid arthritis systemic lupus 61 pan HDAC inhibitor 61 protein kinase inhibitors 61 inflammatory autoimmune 61 endosomal release 61 Fovea Pharmaceuticals subsidiary 61 bispecific antibody 61 non nucleoside inhibitor 61 produces radioisotopes 61 folate analogue metabolic 61 MAGE A3 61 compound perifosine 61 bevacizumab Avastin ® 61 primarily enzymatic reactions 61 IG HCR ;) CO 61 silicon carbide SiC gallium 61 LSE ASM 61 Angiocept 61 pharmacogenomic translational research 61 Litx 61 cetuximab Erbitux R 61 BiTE R 61 Omacetaxine 61 ® lenalidomide 61 itraconazole Sporanox 61 NEBIDO VANTAS SUPPRELIN LA 61 next generation URAT1 61 products MKC# PP 61 Viprovex TM 61 HER2 receptor 61 MyVax R 61 Transdrug ® nanoparticle 61 evaluating tivozanib 61 CTAP# Capsules 61 Liposomal 61 endocrine refractory 61 herpes keratitis Hepatitis C 61 Alessandro Riva 61 Hepatocellular 61 ovarian lung 61 hemorrhagic fever viruses 61 HGS ETR2 61 thymidylate synthase TS 61 thymidylate synthase 61 lymphoid malignancies 61 Adenoviral 61 hepatocellular carcinoma liver 61 targeting PCSK9 61 5 HT4 receptor 61 IMA# 61 oral ferric iron 61 HER pathway 61 SCIB1 61 ADVEXIN p# therapy 61 Colaris Colaris AP 61 product platforms GVAX 61 delta isoform 61 familial amyloidotic polyneuropathy FAP 61 Amgen Neulasta ® 61 small molecule glucokinase 61 interleukin IL -# 61 cytolytic 61 product platforms AZX# 61 Aptamer 61 Staphylococcus aureus Immune Globulin 61 chronically immunosuppressed solid 61 Epothilones 61 chronic eosinophilic leukemia 61 oncolytic viruses 61 HuMax 61 Pralatrexate 61 PKC# 61 Vandetanib 61 CanAg 61 DNA methyltransferase inhibitors 61 K ras mutations 61 Aurora Kinase 61 Albuferon albinterferon alfa 2b 61 isoform selective 61 HPV vaccine protects 61 therapeutic peptide 61 platinum chemotherapeutic 61 Amgen discovers develops manufactures 61 tyrosine kinase receptor 61 lumpectomy cavity following 61 Listeria vaccine 61 SinuNase TM 61 alkylated amino acid 61 malignant ovarian 61 PROACT Phase 2 61 multiple simultaneous immunological 61 VBL proprietary 61 Zolinza 61 CD# CEA 61 Juicy Couture Alberta Ferretti 61 alpha#beta# 61 multiple sclerosis Crohn disease 61 receptor CXCR4 61 Nasdaq AEGR 61 Mg Usa 61 immunotherapeutics 61 Kit CD# positive 61 cladribine Cladribine Tablets 61 small molecule thrombopoietin 61 bladder cervix 61 Anthracycline 61 protein secreted 61 KRAS mutated 61 4SC AG ISIN DE# 61 FOLOTYN ® 61 oral immunomodulatory 61 infectious diseases autoimmune 61 HAAH 61 Peginterferon alfa 2b 61 RNAi therapeutic targeting 61 Evoltra ® 61 lupus multiple sclerosis 61 Tarvacin TM 61 C1 INH deficiency 61 based pretargeting methods 61 visit www.rtanswers.org 61 volociximab 61 GAMMAGARD Liquid ® 61 Through Glycoscience R 61 grade serous ovarian 61 Boiling kills 61 liposomal delivery 61 Janus Kinase 61 MP4 molecule 61 cervical breast 61 delivered RNAi therapeutic 61 imatinib Gleevec 61 adhesion molecule EpCAM 61 recurrent epithelial ovarian 61 TLR9 agonist 61 CYP#A# isoenzyme 61 target enzyme thymidylate 61 inhibit angiogenesis 61 Initiates Phase II 61 Phase 2b Clinical Trial 61 active cellular immunotherapies 61 atopic dermatitis neonatal 61 treat male hypogonadism 61 systemic autoimmune 61 lymphomas leukemias 61 treats acute lymphoblastic 61 fungal infections malaria tuberculosis 61 retinoic acid receptor 61 Surfactant Replacement Therapies SRT 61 Exelixis compounds 61 cosmetic cosmeceutical products 61 HER2 ErbB2 61 CXCR4 receptor 61 Additionally Soligenix 61 dihydrochloride Tablets 61 potently inhibit 61 antiproliferative effects 61 CytoCore develops cost 61 benign prostatic hyperplasia enlarged 60 RAF kinase VEGFR 60 Proxinium TM 60 PORxin TM 60 HuLuc# 60 Bilive TM combined 60 sodium glucose cotransporter 60 directed radiotherapeutic antibody 60 aurora kinase inhibitor 60 HCV polymerase 60 TRANSDUR ® 60 inhalation anthrax cutaneous anthrax 60 gamma amino butyric 60 NASDAQ PPHM clinical 60 Vaccine Shows Promise 60 Kinoid 60 molecular abnormalities 60 Selective Inhibitor 60 c MYC 60 anti miRs antisense oligonucleotide 60 PI3K/mTOR 60 autoimmune uveitis 60 receptor inhibitors 60 Dede Ayew headed 60 Vidaza azacitidine 60 AEG# 60 GlycoPEGylated hemostasis compounds 60 related apoptosis inducing 60 POTELLIGENT ® 60 carcinoembryonic antigen 60 glioblastoma multiforme GBM 60 immunoconjugate 60 nucleoside analog 60 Cojocaru correspondent 60 chemotherapy hormonal therapy 60 liposomal doxorubicin 60 tumor vascular disrupting 60 enhanced skin permeation 60 SAR# [002] 60 Critical Therapeutics Zyflo 60 CIN lesions pre 60 non mutated KRAS 60 PKCi 60 cortisol synthesis 60 oral JAK#/JAK# inhibitor 60 neuronal nicotinic receptors NNRs 60 Receptors GPCRs 60 potent cytotoxic 60 Cutaneous T 60 lysyl oxidase 60 Provecta TM 60 Anticalins R 60 purinergic receptors P#X# 60 XL# XL# XL# XL# 60 eIF 4E 60 bispecific 60 induces apoptosis 60 NS5B polymerase 60 formerly LymphoStat B 60 modulates Akt 60 introduced NEUGENE 60 infection epistaxis dyspnea exfoliative 60 BRAF inhibitors 60 MGd 60 HIF biology 60 anemia COPD 60 Oxidative damage 60 synthetic cannabinoid library 60 Radiation Therapy SIRT 60 myocardial infarction ventricular fibrillation 60 Inc. Nasdaq INFI 60 factor TNF receptor 60 Viprovex R 60 vascular occlusive diseases 60 Oncolytic 60 targets HGF FGFR 60 precursor lesions 60 hypermethylated 60 NSCLC tumors 60 ENMD # 60 tumor antigens 60 detection reagents 60 TGF alpha 60 lung ovarian 60 Raf kinase 60 rapamycin mTOR 60 Tibotec Therapeutics division 60 dermatologic diseases 60 castrate resistant 60 anti amnesic 60 lymphoid tumors 60 cytidine nucleoside analog 60 biologic antibody 60 targets EpCAM expressing 60 topically delivered 60 reversible inhibitors 60 carbohydrate polymer 60 TransVax ™ 60 IAP inhibitors 60 Reximmune C 60 histone methyltransferases HMTs 60 proliferative diseases 60 Galectins 60 TRACON Pharmaceuticals 60 Zemiva TM 60 Completes Patient Enrollment 60 auristatin 60 Cerebral palsy involves 60 metastatic gastric 60 overactive bladder VANTAS R 60 Dose Limiting Toxicity DLT 60 commercializing anti infective 60 small molecule macrocyclic 60 SPINK1 60 Virulizin ® 60 acadesine 60 hyaluronidase enzyme 60 LungAlert TM 60 oncolytic 60 Zarnestra 60 Crizotinib PF # 60 Interferon beta 60 Smac mimetic 60 TURNING INSIGHTS INTO HOPE 60 HER2 positive metastatic breast 60 Papillary 60 Chronic lymphocytic leukemia CLL 60 Denufosol 60 TOCOSOL Camptothecin 60 musculoskeletal metabolic 60 Drug Shows Promise 60 small molecule agonists 60 irinotecan oxaliplatin 60 commercialize MDV# 60 selective orally bioavailable 60 Olaparib 60 prostate pancreatic 60 leukotriene pathway 60 TBC M4 60 anaplastic lymphoma kinase ALK 60 including KIT FLT3 60 investigational integrase inhibitor 60 trial evaluating PRX# 60 acetonide FA